Andreas Jessel

1.7k total citations · 1 hit paper
17 papers, 1.2k citations indexed

About

Andreas Jessel is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Andreas Jessel has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 5 papers in Surgery and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Andreas Jessel's work include Acute Myocardial Infarction Research (7 papers), Cardiac Ischemia and Reperfusion (5 papers) and Cardiac electrophysiology and arrhythmias (4 papers). Andreas Jessel is often cited by papers focused on Acute Myocardial Infarction Research (7 papers), Cardiac Ischemia and Reperfusion (5 papers) and Cardiac electrophysiology and arrhythmias (4 papers). Andreas Jessel collaborates with scholars based in Germany, United States and Canada. Andreas Jessel's co-authors include Pierre Théroux, Bernard Chaitman, Leif Erhardt, John S. Schroeder, J. T. Willerson, H. D. White, G Tognoni, N Danchin, T. Meinertz and R. von Essen and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Andreas Jessel

17 papers receiving 1.2k citations

Hit Papers

Efficacy and Safety of Itepekimab in Patients with Modera... 2021 2026 2022 2024 2021 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma
    2021 258 citations Michael E. Wechsler, Marcella Ruddy et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Jessel Germany 14 601 447 274 228 227 17 1.2k
Marianne Gwechenberger Austria 21 1.0k 1.7× 369 0.8× 122 0.4× 220 1.0× 40 0.2× 61 1.5k
Vlasios Pyrgakis Greece 15 766 1.3× 249 0.6× 168 0.6× 471 2.1× 33 0.1× 35 1.4k
D Mathey Germany 12 882 1.5× 545 1.2× 120 0.4× 117 0.5× 42 0.2× 39 1.5k
Hilmar Dörge Germany 19 987 1.6× 559 1.3× 301 1.1× 257 1.1× 78 0.3× 51 1.5k
Fabrice Ivanés France 18 542 0.9× 247 0.6× 86 0.3× 126 0.6× 48 0.2× 51 972
Stanley Chia Singapore 12 438 0.7× 240 0.5× 60 0.2× 107 0.5× 41 0.2× 25 767
Karla Kurrelmeyer United States 12 935 1.6× 214 0.5× 145 0.5× 448 2.0× 48 0.2× 25 1.4k
Michael P. Flaherty United States 18 303 0.5× 284 0.6× 119 0.4× 252 1.1× 56 0.2× 41 844
Asife Şahinarslan Türkiye 17 415 0.7× 229 0.5× 44 0.2× 181 0.8× 72 0.3× 59 872
Massimo Ragni Italy 17 311 0.5× 159 0.4× 65 0.2× 116 0.5× 51 0.2× 26 786

Countries citing papers authored by Andreas Jessel

Since Specialization
Citations

This map shows the geographic impact of Andreas Jessel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Jessel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Jessel more than expected).

Fields of papers citing papers by Andreas Jessel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Jessel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Jessel. The network helps show where Andreas Jessel may publish in the future.

Co-authorship network of co-authors of Andreas Jessel

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Jessel. A scholar is included among the top collaborators of Andreas Jessel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Jessel. Andreas Jessel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Jessel, Andreas, et al.. (2024). The impact of sphingomyelin on the pathophysiology and treatment response to olipudase alfa in acid sphingomyelinase deficiency. SHILAP Revista de lepidopterología. 2. 101888–101888. 2 indexed citations
2.
Bonella, Francesco, Melissa Wasserstein, Roberto Giugliani, et al.. (2023). Reversal of interstitial lung disease after olipudase alfa enzyme replacement therapy in adults with acid sphingomyelinase deficiency. OA3281–OA3281. 1 indexed citations
3.
Wechsler, Michael E., Marcella Ruddy, Ian Pavord, et al.. (2021). Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma. New England Journal of Medicine. 385(18). 1656–1668. 258 indexed citations breakdown →
4.
Mentzer, Robert M., Robert D. Lasley, Andreas Jessel, & Morris Karmazyn. (2003). Intracellular sodium hydrogen exchange inhibition and clinical myocardial protection. The Annals of Thoracic Surgery. 75(2). S700–S708. 50 indexed citations
5.
Boyce, Steven W., Claus Bartels, Roberto Bolli, et al.. (2003). Impact of sodium-hydrogen exchange inhibition by cariporide on death or myocardial infarction in high-risk CABG surgery patients: results of the CABG surgery cohort of the GUARDIAN study. Journal of Thoracic and Cardiovascular Surgery. 126(2). 420–427. 82 indexed citations
6.
Gavard, Jeffrey A., Bernard Chaitman, Shunta Sakai, et al.. (2003). Prognostic significance of elevated creatine kinase MB after coronary bypass surgery and after an acute coronary syndrome: results from the GUARDIAN trial. Journal of Thoracic and Cardiovascular Surgery. 126(3). 807–813. 18 indexed citations
7.
Weber, Willi, Lutz Harnisch, & Andreas Jessel. (2002). Lessons learned from a phase III population pharmacokinetic study of cariporide in coronary artery bypass graft surgery. Clinical Pharmacology & Therapeutics. 71(6). 457–467. 5 indexed citations
8.
Chaitman, Bernard, Pierre Théroux, Jeffrey A. Gavard, et al.. (2001). Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release. Journal of the American College of Cardiology. 38(4). 1070–1077. 105 indexed citations
9.
Théroux, Pierre, Bernard Chaitman, N Danchin, et al.. (2000). Inhibition of the Sodium-Hydrogen Exchanger With Cariporide to Prevent Myocardial Infarction in High-Risk Ischemic Situations. Circulation. 102(25). 3032–3038. 320 indexed citations
10.
11.
Scholz, Wolfgang, Andreas Jessel, & Udo Albus. (1999). Development of the Na+/H+ Exchange Inhibitor Cariporide as a Cardioprotective Drug: From the Laboratory to the GUARDIAN Trial. Journal of Thrombosis and Thrombolysis. 8(1). 61–70. 17 indexed citations
12.
Essen, R. von, Uwe Zeymer, Ulrich Tebbe, et al.. (1998). HBW 023 (recombinant hirudin) for the acceleration of thrombolysis and prevention of coronary reocclusion in acute myocardial infarction. Coronary Artery Disease. 9(5). 265–272. 14 indexed citations
13.
Häfner, G., H.-J. Rupprecht, Wolfram Terres, et al.. (1996). Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris. European Heart Journal. 17(8). 1207–1215. 17 indexed citations
14.
Zeymer, Uwe, R. von Essen, H. R. Michels, et al.. (1995). Recombinant hirudin and front-loaded alteplase in acute myocardial infarction: Final results of a pilot study HIT-I (hirudin for the improvement of thrombolysis). European Heart Journal. 16(suppl D). 22–27. 25 indexed citations
15.
Römisch, Jürgen, et al.. (1995). Investigation of Activated Prothrombin Complex Concentrate as Potential Hirudin Antidote in Animal Models. Pathophysiology of Haemostasis and Thrombosis. 25(4). 182–192. 17 indexed citations
16.
Terres, Wolfram, Matthias Luz, Andreas Jessel, et al.. (1995). Recombinant hirudin (HBW 023) prevents troponin T release after coronary angioplasty in patients with unstable angina. Journal of the American College of Cardiology. 26(7). 1637–1642. 37 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marianne Gwechenberger Breakdown of academic impact, for papers by Vlasios Pyrgakis Breakdown of academic impact, for papers by D Mathey Breakdown of academic impact, for papers by Hilmar Dörge Breakdown of academic impact, for papers by Fabrice Ivanés Breakdown of academic impact, for papers by Stanley Chia Breakdown of academic impact, for papers by Karla Kurrelmeyer Breakdown of academic impact, for papers by Michael P. Flaherty Breakdown of academic impact, for papers by Asife Şahinarslan Breakdown of academic impact, for papers by Massimo Ragni
Rankless by CCL
2026